Dear Editor:

*Severe Acute Respiratory Syndrome Coronavirus type 2* (SARS-CoV-2) infection is the cause of the so-called coronavirus disease 2019 (COVID-19), which has currently spread causing a global pandemic.[@bib0030]

There is little information about cutaneous involvement caused by this virus, mainly collected in an initial series of adult patients from Lombardy[@bib0030] (maculopapular, urticariform, or varicelliform rashes) and isolated cases of petechial rashes,[@bib0035] digital gangrene and livedoid lesions.[@bib0040] We report a descriptive and multicenter case series collected in our setting.

During the week of 13th to 19th April 2020, all suspected cases of cutaneous lesions caused by COVID-19 from the Region of Murcia were collected by tele-consultation or visit to admitted patients. To do this, we requested primary care doctors to electronically report any cutaneous findings in patients with disease confirmed by diagnostic tests or in their cohabitants.

During the study period, 196 cases were confirmed by serology (*Polymerase Chain* *Reaction* \[PCR\]) in our region. That means that from 1463 initial cases, a total of 1659 were reached at the end of data collection.

Throughout these 7 days, of the 86 cases initially assessed, 16 met the requirements of *de novo* cutaneous lesion development together with positive evidence of infection or close contact with cohabitants of COVID-19 disease confirmed by diagnostic tests ([Table 1](#tbl0005){ref-type="table"} ). The mean age of this group was 29 years (range: 8 months--85 years, median:21 years). 56% of cases occurred in women.Table 1Demographic and clinical data of cases with COVID-19 or in close contact with confirmed cases.Table 1CaseAge (years)Sex[a](#tblfn0005){ref-type="table-fn"}Type of lesionSite[b](#tblfn0010){ref-type="table-fn"}FeverRespiratoryCutaneous onsetAdmissionICUTest\
COVID-19Close COVID-19 contact12FHivesULNoNoNANoNoNoYes21MChilblainFeetNoNoNANoNoNoYes316FChilblainFeetNoNoNANoNo--Yes40FRashFaceYESYes17 days laterNoNoPCR^−^Yes543MRashUL\
LLYesYes3 days laterNoNoIgM^+^Yes647FPapules and bruisesULYesYes14 days laterYesNoIgM^+^Yes756MHivesTrunkNoYes37 days laterYesYesPCR^+^NK862MUlcerSacralNoYes20 days laterYesYesPCR^+^NK985FAcrocyanosisHands and feetNoYes24 days laterYesNoPCR^+^NK1070FErythema multiformeCircumoralNoYes18 days laterYesYesPCR^+^NK115MHivesGeneralYesNo2 days beforeNoNoPCR^−^Yes1234MFollicular papulesGeneralYesNo14 days laterNoNoPCR^−^Yes135FHivesGeneralNoNoNANoNoPCR^−^Yes1418FTineaNeckYesYes4 days laterNoNoPCR^+^NK150MRashTrunk\
ULNoNoNANoNoNoYes1625FKeratosis pilarisUL\
LLNoYesNANoNoPCR^+^NK150MRashTrunk\
ULNoNoNANoNoNoYes1625FKeratosis pilarisUL\
LLNoYesNANoNoPCR^+^NK[^1][^2]

The most common cutaneous reaction was hives (25%), followed by rashes (19%) and chilblain-like lesions (12%). Furthermore, we found another group of heterogeneous cutaneous lesions of remarkably diverse origin (infectious, vascular, inflammatory, traumatic, keratosis pilaris, and acrocyanosis). Thirty seven percent of cases associated fever and 56% respiratory symptoms, from cough to double pneumonia.

Unlike the series reported in Lombardy[@bib0030] in which the most common cutaneous manifestation was erythematous rash, hives was the most common finding in our series. Previous studies showed that the most common cause of hives in children is infections, especially those of the respiratory tract.[@bib0045]

Keratosis pilaris is a common finding in children with atopic diathesis. We have found no evidence in the scientific literature of keratosis pilaris onset in patients with COVID-19. We do not know the mechanisms that may justify this finding in the context of COVID-19 disease.

One of the findings in our series is acrocyanosis. This sign reflects the peripheral hypoxia in probable relation to the thrombotic phenomena that have been described in the disease, both cutaneously[@bib0040] as well as in other organ\'s vessels, including the lungs, heart, or brain, or by processes such as disseminated intravascular coagulation.[@bib0050] In our case, we observed this finding in a patient with respiratory failure who required hospital admission.

This study has some limitations. Firstly, a restricted access to diagnostic tests, which excluded cases that presented with guiding symptoms of COVID-19, but which were not confirmed by PCR or serology; on the other hand, the elective use of tele-dermatology has made it difficult to take biopsies of these lesions.

More studies are needed that collect cutaneous manifestations in patients with COVID-19. Knowledge of these cutaneous reactions and study of the temporal patterns of onset of these findings could help to identify patients without other symptoms of this disease, especially in those regions where diagnostic tests are not available.
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[^1]: Gender: M: male; F: female.

[^2]: Site: location of lesions: LL: lower limbs; UL: upper limbs.

    NK: not known; NA: not applicable; ICU: intensive care unit.

    Cutaneous onset: offset between systemic respiratory symptoms and cutaneous lesions.
